Abstract
ObjectiveTo clarify the length and volume reduction of seminal vesicles (SVs) after neo-adjuvant hormonal therapy (NHT), in order to help contour the optimal SV included into high-dose clinical target volume (CTV) for radiotherapy in intermediate- and high-risk patients. MethodsMR images both before and after NHT (5.3 ± 2.2 months) were collected from thirty-one patients with cT2-4N0M0 prostate cancer. SV volume was measured in axial T1WI, while SV length was obtained in a reconstructed oblique coronary plane through its long axial from a 3D sequence. ResultsSVs showed evident reduction both in length and volume (length: median 12.1%, range 4.0%–28.0%; volume: median 39.9%, range 9.4%–66.2%). For SVs with and without MR detected involvement, length shortening were (16.7 ± 4.8)% and (11.1 ± 4.4)% (P < 0.001); for involved SVs and lesions, volume reduction were (41.0 ± 16.0)% and (66.3 ± 14.4)%, respectively (P < 0.001), both indicating a more sensitive response to NHT of the involved portion than normal SV. ConclusionsBoth volume and length of the SV will be reduced after receiving NHT. Besides, the invaded segments shrink more than normal SV tissue, indicating that SV portion included within the CTV can be reduced.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
